Tradestie Institutional Equity Comparison Engine

QNRX vs KPRX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KPRX Overall Edge

KPRX Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Kiora Pharmaceuticals, Inc. Common Stock (KPRX) driven by superior Valuation, Momentum & Technical while QNRX counters with relative strength in Growth & Margin. Fundamentally, QNRX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus KPRX at 1.7x Forward P/E and -890.2% operating margin (+0.0% YoY). In options structure, QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against KPRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner KPRX
QNRX N/M vs KPRX 1.7x Fwd P/E
Growth & Margin Winner QNRX
Op Margin 0.0% vs -890.2% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner KPRX
1Y -82.0% vs -62.5% ยท 52W Pos 0% vs 0%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
QNRX NASDAQ
Quoin Pharmaceuticals, Ltd. American Depositary Shares
Pharmaceutical Preparations
$3.28
-2.35% 1D
Market Cap $16.1M
1M Return -18.2%
1Y Return -81.96%
Forward P/E N/M
Unified AI Score
46.1 / 100 HOLD
Tech 38.0 Fund 47.0 Flow 50.0 Mom 64.0
KPRX NASDAQ
Kiora Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$0.72
-12.28% 1D
Market Cap $3.6M
1M Return -68.96%
1Y Return -62.49%
Forward P/E 1.7x
Unified AI Score
47.5 / 100 HOLD
Tech 45.0 Fund 46.0 Flow 50.0 Mom 55.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: QNRX -81.96% KPRX -62.49% Spread: +19.47 pp (KPRX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
QNRX TTM Op. Margin: 0.0% KPRX TTM Op. Margin: -890.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QNRX vs KPRX. Trailing 12-month operating profitability (QNRX 0.0% vs KPRX -890.2%) and valuation multiples (QNRX N/M vs KPRX 1.7x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: QNRX (3) vs KPRX (4)
Institutional Metric QNRX KPRX Criterion Row Winner
Market Capitalization Scale $16.1M $3.6M Larger Scale QNRX
Trailing P/E Ratio Valuation 7.6x 1.7x Lower Multiple KPRX
Forward P/E Ratio Valuation N/M 1.7x Lower Multiple KPRX
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% -890.2% Higher Margin QNRX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -142.6% -67.7% Higher ROE KPRX
52-Week Range Position Momentum 0% ($3โ€“$24) 0% ($1โ€“$3) Stronger Trend Tie
Beta / 30D Volatility Risk Regime 1.34ฮฒ ยท 74% Vol 1.62ฮฒ ยท 126% Vol Lower Realized Risk QNRX
Unified Institutional Score Composite Signal 46.1 / 100 (HOLD) 47.5 / 100 (HOLD) Higher Composite KPRX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full QNRX vs KPRX Buy Guide
QNRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live QNRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KPRX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KPRX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither QNRX nor KPRX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.